Delivery Order SPE2DB25D3022-SPE2DB25FWCBV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,946.39 to AmerisourceBergen Drug Corp for Cevimeline HCL 30 mg capsules (100 count) on November 6, 2025, with completion scheduled for November 7, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999, running through December 2026. The pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $2,344.44 firm-fixed-price delivery order is for the supply of Cevimeline Hydrochloride 30 mg capsules, a medication used to treat dry mouth. This specific award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, which provides a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Cevimeline HCL 30 mg capsules, with a firm fixed price of $1,038.61 and a period of performance through May 1, 2025. The contract is not set aside and was awarded on April 30, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- The Defense Logistics Agency awarded a $311,880 delivery order to AmerisourceBergen Drug Corporation for 100 capsules of 30mg Cevimeline hydrochloride to be delivered to its Conshohocken, Pennsylvania facility by July 25, 2023. The firm fixed price order was issued under an indefinite-delivery/indefinite-quantity contract vehicle to supply pharmaceutical products in support of Department of Defense health programs. No subcontractors or set aside designations were specified. The Defense Logistics...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $6,558.84 firm fixed-price delivery order is for 4,560,816,582 capsules of the drug Cevimeline HCL 30 mg, to be delivered by May 4, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a range of pharmaceutical...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $77,970 to Amerisourcebergen Drug Corporation to provide 100 capsules of the pharmaceutical Cevimeline hydrochloride. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The order period of performance is June 26-27, 2023. As a major distributor of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen will fulfill this order to supply the Defense...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,306.92 firm fixed-price delivery order is for the supply of 4560488341 - Cevimeline HCL 30 mg capsules, a prescription medication. The contract has an ultimate completion date of April 5, 2023 and was awarded on April 4, 2023. AmerisourceBergen, a for-profit organization, is the prime contractor and does not have any set-aside designation. This...
- The Defense Logistics Agency awarded a $6,565.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4562031748 Cevimeline hydrochloride 30 mg capsules in quantities of 100. The prime contractor, Amerisourcebergen Drug Corporation Corporate Office Division, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania within the period of performance of September 1, 2023 through September 5, 2023. The Defense Logistics Agency is the funding agency for...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at approximately $1,900 to Amerisourcebergen Drug Corp Corporate Office Division. The order is for 100 capsules of the pharmaceutical Cevimeline hydrochloride 30 mg to be delivered to a location in Conshohocken, Pennsylvania by July 19, 2023. No additional details were provided on the original solicitation or whether this delivery order is associated with a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4561055140 Cevimeline HCL 30 mg capsules. The $3,630.50 firm fixed-price delivery order (SPE2DB23FT69B) has a completion date of May 26, 2023. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
- SPE2DB25D3022Indefinite Delivery Contract
- SPE2DB25D3022-SPE2DB25FWCBVDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Cevimeline HCL 30 mg capsules (100-count units) with a ceiling value of $2,221.57. This firm fixed-price delivery order, which is expected to be completed by July 31, 2025, represents a competitively awarded, non-set-aside contract with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. Cevimeline is a cholinergic medication used to treat dry mouth and other conditions, reflecting the breadth of pharmaceutical products supplied by AmerisourceBergen to support federal healthcare needs. This delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and prime contractor to the federal government, AmerisourceBergen serves critical supply chain functions for military and veteran healthcare systems, providing an extensive portfolio of medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's designation as a prime vendor reflects its established capability to meet federal procurement standards and deliver essential pharmaceutical products efficiently to support Defense Health Agency operations and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 7/30/25 |